← All stocks

EXELIXIS, INC.

EXEL Net selling
CIK 0000939767 #814 in the set updated 18 Sep 2026
Bought (12 mo)
$1.19M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$42.24M
$2.54M on a plan · $12.75M straight out of an exercise
Sold at will
$26.95M
16 of 32 sales
Net
−$41.06M
−$25.76M against sales at will

By person

17 insiders · 34 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Aftab Dana
EVP, Research and Development
$7.70M (4)
−$7.70M
594,741
0.2400%
$31.91M
+18.6%
Haley Patrick J.
EVP, Commercial
$7.60M (7)
−$7.60M
357,638
0.1443%
$19.19M
−5.0%
Smith Julie
Director
$4.69M (3) scheduled
−$4.69M
28,957
0.0117%
$1.55M
+168.7%
WYSZOMIERSKI JACK L
Director
$4.58M (2) scheduled
−$4.58M
284,384
0.1148%
$15.26M
−18.6%
Senner Christopher J.
EVP and CFO
$4.56M (3)
−$4.56M
952,317
0.3843%
$51.10M
+32.0%
PAPADOPOULOS STELIOS
Director
$4.36M (1)
−$4.36M
1,197,595
0.4833%
$64.26M
−6.4%
POSTE GEORGE
Director
$2.74M (1)
−$2.74M
127,199
0.0513%
$6.83M
−36.1%
Beckerle Mary C
Director
$1.93M (4) scheduled
−$1.93M
16,079
0.0065%
$862.80K
−53.1%
Oliver Bob
Director
$1.33M (2) scheduled
−$1.33M
29,487
0.0119%
$1.58M
−20.3%
JOHNSON DAVID EDWARD
Director
$1.19M (1)
+$1.19M
1,553,262
0.6269%
$83.35M
+1.8%
Hefti Brenda
SVP and General Counsel
$1.15M (2) scheduled
−$1.15M
106,762
0.0431%
$5.73M
+17.8%
Freire Maria C
Director
$949.16K (1) scheduled
−$949.16K
109,186
0.0441%
$5.86M
+20.0%
Eckhardt Sue Gail
Director
$660.83K (2) scheduled
−$660.83K
16,079
0.0065%
$862.80K
−53.1%
MORRISSEY MICHAEL
President and CEO
3,366,335
1.36%
$180.64M
+40.2%
Hessekiel Jeffrey
EVP & General Counsel
693,396
0.2798%
$37.21M
+9.9%
Peterson Amy C.
EVP Prod Dev & Med Aff & CMO
465,393
0.1878%
$24.97M
+44.5%
Heyman Tomas J.
Director
50,649
0.0204%
$2.72M
+36.8%
Insider
Date
Role
Action
Shares
Price
Amount
Beckerle Mary C
10 Aug 2026
Director
Sold on a plan
9,812
$53.66
$526.51K
Eckhardt Sue Gail
1 Jun 2026
Director
Sold on a plan
9,812
$50.14
$491.97K
WYSZOMIERSKI JACK L
1 Jun 2026
Director
Sold on a plan
3,925
$50.55
$198.41K
Aftab Dana
26 May 2026
EVP, Research and Development
Sell
43,451
$50.35
$2.19M
Haley Patrick J.
20 May 2026
EVP, Commercial
Sell
32,110
$49.81
$1.60M
Hefti Brenda
18 May 2026
SVP and General Counsel
Sold on a plan
6,625
$50.21
$332.64K
Senner Christopher J.
18 May 2026
EVP and CFO
Sell
34,901
$50.00
$1.75M
POSTE GEORGE
7 May 2026
Director
Sell
60,000
$45.71
$2.74M
Freire Maria C
7 May 2026
Director
Sold after exercise
20,634
$46.00
$949.16K
Beckerle Mary C
7 May 2026
Director
Sold after exercise
7,712
$48.45
$373.65K
Aftab Dana
24 Feb 2026
EVP, Research and Development
Sell
47,918
$44.50
$2.13M
Aftab Dana
19 Feb 2026
EVP, Research and Development
Sell
29,873
$44.35
$1.32M
Hefti Brenda
18 Feb 2026
SVP and General Counsel
Sold on a plan
18,669
$44.01
$821.62K
Smith Julie
18 Feb 2026
Director
Sold after exercise
20,030
$44.30
$887.33K
Smith Julie
18 Feb 2026
Director
Sold after exercise
44,087
$44.50
$1.96M
WYSZOMIERSKI JACK L
18 Feb 2026
Director
Sold after exercise
99,574
$44.01
$4.38M
Haley Patrick J.
17 Feb 2026
EVP, Commercial
Sell
64,778
$43.50
$2.82M
Haley Patrick J.
17 Feb 2026
EVP, Commercial
Sell
3,036
$43.84
$133.10K
Senner Christopher J.
17 Feb 2026
EVP and CFO
Sell
30,617
$43.67
$1.34M
Smith Julie
17 Feb 2026
Director
Sold after exercise
42,422
$43.33
$1.84M
Oliver Bob
13 Feb 2026
Director
Sold after exercise
21,162
$43.90
$929.01K
Oliver Bob
13 Feb 2026
Director
Sold after exercise
9,088
$43.61
$396.33K
Eckhardt Sue Gail
13 Feb 2026
Director
Sold on a plan
3,856
$43.79
$168.85K
MORRISSEY MICHAEL
13 Feb 2026
President and CEO
Exercised, kept
494,700
$21.31
$10.54M
Senner Christopher J.
13 Feb 2026
EVP and CFO
Sell
34,278
$43.00
$1.47M
JOHNSON DAVID EDWARD
25 Nov 2025
Director
Buy indirect
27,532
$43.12
$1.19M
Haley Patrick J.
21 Nov 2025
EVP, Commercial
Sell
28,043
$42.58
$1.19M
Haley Patrick J.
20 Nov 2025
EVP, Commercial
Sell indirect
10,648
$41.77
$444.77K
Haley Patrick J.
20 Nov 2025
EVP, Commercial
Sell indirect
23,539
$41.93
$986.99K
Haley Patrick J.
20 Nov 2025
EVP, Commercial
Sell
10,000
$42.11
$421.10K
PAPADOPOULOS STELIOS
12 Nov 2025
Director
Sell
100,000
$43.55
$4.36M
Beckerle Mary C
11 Nov 2025
Director
Sold after exercise
18,838
$41.90
$789.31K
Beckerle Mary C
11 Nov 2025
Director
Sold after exercise
5,784
$42.03
$243.10K
Aftab Dana
11 Nov 2025
EVP, Research and Development
Sell
48,383
$42.50
$2.06M

What was left out

Form 4 filings counted 54
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 10
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 4,861,109
History held since 2 Sep 2016